Liposomal concentrated & unflavored liquid form of Vitamin B7 (Biotin) $30.00
A Medical Food for the dietary management of Mitochondrial Disease or Biotinidase Deficiency. A Liposomal concentrated & unflavored liquid form of Vitamin B7 (Biotin)
Cyto® B7 is a medical food containing liposomal & concentrated liquid biotin (Vitamin B7).
Product Form: Liposomal Liquid
Indications: Diagnosed Mitochondrial disorders and Biotinidase Deficiency
Advantages:
Product form is liposomal liquid for enhanced absorption
A highly concentrated liquid form allowing small volume dosages
Delivers 10mg of Biotin (Vitamin B7) per mL
It may be consumed orally or via tube feeding.
Vegetarian, non-GMO, and gluten-free
Sugar-free and naturally flavored
Manufactured in an FDA-Inspected and cGMP Certified facility
Made in the USA
Reimbursement Code: 57771-0001-92
HCPCS Code: B4155
Cyto® B7 is free of GMOs and is allergen tested at No-Detectable Limit (NDL) for eggs, dairy, fish, crustacean, soy, gluten, corn, tree nuts, and peanut.
Cyto B7 is solubleand can be consumed either orally or via tube feeding. The daily intake of this liquid is to be determined by your physician or dietitian. It is formulated to be consumed or administered enterally under the supervision of a physician. Each serving of Cyto B7 contains 10 milligrams of Biotin.
Measure the amount of liquid required to meet your serving requirements.
Take directly by mouth or add liquid to any beverage, stir well and then consume.
For tube feeding, add liquid to the formula and stir well. Formula mixture should be used within 4 hours.
Storage
All bottles should be kept in a cool, dry place. Reseal opened bottles and use within three months.
Warning
This product is intended only for those under the supervision of a healthcare professional. It is not for the general population of consumers. Not for parenteral use or for use as a sole source of nutrition. This product is for individuals with Mitochondrial Disease or Biotinidase Deficiencies over the age of 1 year.
Reviews
There are no reviews yet.